A cure for genetic heart conditions could reach trials in only 5 years, and it “rewrites” DNA. Experts explain the potential ...

Gene Therapy Market Gene therapy market surges on breakthroughs in genome editing, rising chronic & genetic disease cases, regulatory appro ...

A major inquiry published in 2021 highlighted substandard care and poor awareness of sickle cell disease among health professionals. Carla Delgado explores whether things have improved for patients In ...

CRISPR gene editing shows potential for treating genetic diseases. Explore how it may impact Down syndrome treatment and future healthcare ethics.

Genome editing, also referred to as gene editing, is a group of technologies that enables scientists to change an organism’s ...

Daniel Cressy has dreams of becoming a pilot one day, but was told the only way he could get a license to fly is if his ...

Editas' share price has struggled due to clinical setbacks, but recent focus on in-vivo gene editing offers renewed hope and ...

Oregon will initially focus on providing lower-cost therapies for people living with sickle cell disease, a genetic blood ...

The multiagent AI system, dubbed “CRISPR-GPT,” is designed to interact and reason with human users as they execute ...

After decades of excruciating pain, a breakthrough sickle cell disease treatment made all the difference for one patient.

Fulcrum Therapeutics reports promising late-stage data for sickle cell drug pociredir, with notable hemoglobin improvements.

At least 29 police recruits have died during basic training in the last decade, with most dying of exertion, dehydration, ...